Generic
Bexitrol F HFA 25/250 Inhaler contains two active ingredients: Salmeterol Xinafoate 25mcg and Fluticasone Propionate 250mcg, both of which are used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Description
Bexitrol F HFA 25/250 Inhaler is a combination medication that helps open the airways and makes breathing easier. It is used regularly to manage asthma and COPD symptoms, improving the patient's quality of life by reducing flare-ups and controlling symptoms.

Benefits
Bexitrol F HFA 25/250 Inhaler offers effective asthma and COPD management, improving lung function, and reducing the frequency of exacerbations. The combination of a long-acting bronchodilator (Salmeterol) and a corticosteroid (Fluticasone Propionate) provides both symptom relief and long-term control of the conditions.

Ingredients

• Salmeterol Xinafoate 25mcg
• Fluticasone Propionate 250mcg

Uses and Doses
This inhaler is prescribed for the treatment of asthma and COPD. Adults and adolescents aged 12 years and older should take 2 puffs of 25mcg Salmeterol and 250mcg Fluticasone Propionate twice daily. Children aged 4-12 years should take 2 puffs of 25mcg Salmeterol and 50mcg Fluticasone Propionate twice daily.

Side Effects
Common side effects include nausea, vomiting, respiratory tract infections, fungal infections of the mouth, sore throat, headache, hoarseness of voice, musculoskeletal pain, and increased heart rate.

How to Use
Shake the inhaler well before use. Breathe in from the mouth while pressing down the inhaler to release the medication. Hold your breath for about 10 seconds, then exhale. Rinse your mouth after inhaling to prevent fungal infections.

Pregnancy & Lactation
Use during pregnancy or breastfeeding should only be considered if the benefit to the mother outweighs the risk to the baby. There is limited experience with the use of Salmeterol and Fluticasone during pregnancy and breastfeeding.

Precautions and Warnings
Use with caution in patients with active or inactive pulmonary tuberculosis, thyrotoxicosis, or patients at risk for decreased bone mineral content. It is essential to use this medication regularly and avoid abrupt cessation of therapy.

Safety Information
Store in a cool, dry place below 30°C, protected from light and moisture. Keep out of the reach of children. Patients should avoid exposure to triggers that may exacerbate asthma or COPD symptoms.

Indications
Bexitrol F HFA 25/250 is indicated for the regular treatment of asthma and COPD where a combination of a long-acting β2-agonist and an inhaled corticosteroid is needed.

Pharmacology
Salmeterol Xinafoate is a long-acting β2-agonist that helps to relax airway muscles, improving airflow. Fluticasone Propionate is a corticosteroid that reduces inflammation in the airways, enhancing breathing.

Therapeutic Class
Long-acting selective β-adrenoceptor stimulants and respiratory corticosteroids.

Storage Conditions
Store below 30°C, protected from light and moisture. Keep out of reach of children.

FAQ

1. Can I use Bexitrol F HFA 25/250 for sudden asthma attacks?
   No, this inhaler is not suitable for relieving sudden asthma attacks. Use a quick-relief inhaler for that purpose.
2. Can I stop using Bexitrol F HFA if I feel better?
   No, continue using the inhaler as prescribed by your doctor to prevent symptoms from returning or worsening.
3. What should I do if I miss a dose?
   Take the missed dose as soon as you remember, unless it’s almost time for your next dose. Do not double the dose.

Disclaimer
This information is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Keywords: Asthma, COPD, inhaler, Salmeterol, Fluticasone Propionate, respiratory health, a bronchodilator, corticosteroid, lung function, chronic asthma, asthma control, inhalation therapy, lung inflammation, long-acting β2-agonist, airway obstruction, respiratory care, lung disease, Beximco Pharmaceuticals, asthma relief, COPD treatment.